MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grant, A. O.
Right arrow Articles by Moorman, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grant, A. O.
Right arrow Articles by Moorman, J. R.

The role of inactivation in open-channel block of the sodium channel: studies with inactivation-deficient mutant channels

AO Grant, JE John, VV Nesterenko, CF Starmer and JR Moorman

Department of Medicine, Duke University School of Medicine, Durham, North Carolina 27710, USA. aog@carlin.mc.duke.edu

Inactivation has been implicated as an important determinant of the block of Na+ channel by local anesthetic-class drugs. This proposition has been difficult to examine because agents used to modify inactivation change other channel properties and both inactivated and blocked channels do not conduct. We used site-directed mutagenesis of Phe1304 to glutamine in the linker between the third and fourth domains of the mu-1 Na+ channel to slow inactivation. Wild-type and mutant channels were expressed in frog oocytes. Macropatch and single-channel currents were recorded in cell-attached membrane patches. The F1304Q mutation increased mean open time (1.7 fold at -20 mV) and reduced the probability that the channel would fail to open. Closed times were best fit by a double-exponential function, suggesting that the inactivated state transitions were no longer absorbing. In wild-type channels, 100 microM disopyramide decreased mean open time from 1.64 +/- 0.08 to 0.34 +/- 0.04 msec. Total open time per trial was decreased 2-fold. There also was a marked increase in the fraction of null sweeps. In the inactivation-deficient mutant channel, mean and total open times were also reduced. These data indicate that even when inactivation is slowed by a localized specific mutation, open-channel block by disopyramide persists. Inactivation may not be a necessary requirement for open- channel block.

Volume 50, Issue 6, pp. 1643-1650, 12/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 Mol. Pharmacol.Home page
J.-H. Lee, S. M. Jeong, J.-H. Kim, B.-H. Lee, I.-S. Yoon, J.-H. Lee, S.-H. Choi, D.-H. Kim, H. Rhim, S. S. Kim, et al.
Characteristics of Ginsenoside Rg3-Mediated Brain Na+ Current Inhibition
Mol. Pharmacol., October 1, 2005; 68(4): 1114 - 1126.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
M. E. O'Leary, M. Digregorio, and M. Chahine
Closing and Inactivation Potentiate the Cocaethylene Inhibition of Cardiac Sodium Channels by Distinct Mechanisms
Mol. Pharmacol., December 1, 2003; 64(6): 1575 - 1585.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
J C Hancox, K C R Patel, and J V Jones
Antiarrhythmics---from cell to clinic: past, present, and future
Heart, July 1, 2000; 84(1): 14 - 24.
[Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1996 by the American Society for Pharmacology and Experimental Therapeutics